Dr Cui joined the Neuroinflammation Lab in late 2018 as a PhD student, under the supervision of Professor Trent Woodruff. His research project focused on the preclinical development of C5aR1 antagonists for the treatment of various inflammatory diseases, including inflammatory bowel disease (IBD). In 2023, he was appointed as a postdoctoral research fellow under the supervision of Dr John Lee. His current project focuses on investigating new therapeutics for neurodegenerative diseases. Dr Cui’s recent experience includes working with LC-MS/MS, QdToF, and timsToF fleX-MALDI-2, for conducting pharmacokinetics, neurotransmitter, and spatial metabolomic and lipidomic studies.